Pub Date : 2022-04-01DOI: 10.22122/AHJ.2022.195961.1247
Mohammad Hadi Nematollahi, Mohammad Ali Ahmadianmoghadam, Mehrnaz Mehrabani, Masoud Moghadari, Adel Ghorani-Azam, Mehrzad Mehrbani
Background: Medicinal plants have revealed much attention as an alternative or complementary treatment for opioid withdrawal syndrome. The current review collects all available literature to verify the efficiency of herbal remedies in the management of symptoms associated with opioid withdrawal.
Methods: A systematic literature search was conducted from January 1990 to May 2021 on four bibliographic databases (Scopus, PubMed, Embase, and Web of Science) using the search terms "medicinal plant", "withdrawal syndrome", "opioid", and all their equivalents. All randomized controlled trials (RCTs), published in the English language were included for data synthesis. The search was performed according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA). The Cochrane risk of bias tool was used to verify the quality of the included clinical trials.
Findings: A total of 12 RCTs were collected and used for data synthesis. The results of these studies indicated that herbal medicines were effective in treating opioid withdrawal syndrome and could alleviate the withdrawal symptoms, such as abdominal constrictions, diarrhea, bone pain, perspiration, and insomnia, when compared to conventional medications such as buprenorphine, clonidine, and methadone. However, more than 30% of RCTs were found to be at high risk of bias in the areas of selection, performance, detection, attrition, and reporting.
Conclusion: Although several RCTs have proven that herbal remedies are effective in reducing opioid withdrawal symptoms, the findings need to be viewed more carefully. Further RCTs with more participants, longer duration, and less risk of bias are needed in the claimed cases.
背景:药用植物作为阿片类戒断综合征的替代或补充治疗已受到广泛关注。目前的综述收集了所有可用的文献,以验证草药治疗阿片类药物戒断相关症状的有效性。方法:系统检索1990年1月至2021年5月Scopus、PubMed、Embase和Web of Science四个书目数据库的文献,检索词为“药用植物”、“戒断综合征”、“阿片类药物”及其等同物。所有以英文发表的随机对照试验(RCTs)纳入数据综合。根据系统评价和荟萃分析(PRISMA)的首选报告项目进行搜索。采用Cochrane偏倚风险工具验证纳入临床试验的质量。结果:共收集了12项随机对照试验,用于数据综合。这些研究结果表明,与丁丙诺啡、可口定、美沙酮等传统药物相比,草药治疗阿片类药物戒断综合征是有效的,可以减轻戒断症状,如腹部收缩、腹泻、骨痛、出汗、失眠。然而,超过30%的随机对照试验在选择、表现、检测、减员和报告等方面存在高偏倚风险。结论:虽然一些随机对照试验已经证明草药在减少阿片类药物戒断症状方面是有效的,但研究结果需要更仔细地看待。进一步的随机对照试验需要更多的参与者、更长的持续时间和更低的偏倚风险。
{"title":"Herbal therapy in opioid withdrawal syndrome: A systematic review of randomized clinical trials.","authors":"Mohammad Hadi Nematollahi, Mohammad Ali Ahmadianmoghadam, Mehrnaz Mehrabani, Masoud Moghadari, Adel Ghorani-Azam, Mehrzad Mehrbani","doi":"10.22122/AHJ.2022.195961.1247","DOIUrl":"https://doi.org/10.22122/AHJ.2022.195961.1247","url":null,"abstract":"<p><strong>Background: </strong>Medicinal plants have revealed much attention as an alternative or complementary treatment for opioid withdrawal syndrome. The current review collects all available literature to verify the efficiency of herbal remedies in the management of symptoms associated with opioid withdrawal.</p><p><strong>Methods: </strong>A systematic literature search was conducted from January 1990 to May 2021 on four bibliographic databases (Scopus, PubMed, Embase, and Web of Science) using the search terms \"medicinal plant\", \"withdrawal syndrome\", \"opioid\", and all their equivalents. All randomized controlled trials (RCTs), published in the English language were included for data synthesis. The search was performed according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA). The Cochrane risk of bias tool was used to verify the quality of the included clinical trials.</p><p><strong>Findings: </strong>A total of 12 RCTs were collected and used for data synthesis. The results of these studies indicated that herbal medicines were effective in treating opioid withdrawal syndrome and could alleviate the withdrawal symptoms, such as abdominal constrictions, diarrhea, bone pain, perspiration, and insomnia, when compared to conventional medications such as buprenorphine, clonidine, and methadone. However, more than 30% of RCTs were found to be at high risk of bias in the areas of selection, performance, detection, attrition, and reporting.</p><p><strong>Conclusion: </strong>Although several RCTs have proven that herbal remedies are effective in reducing opioid withdrawal symptoms, the findings need to be viewed more carefully. Further RCTs with more participants, longer duration, and less risk of bias are needed in the claimed cases.</p>","PeriodicalId":33943,"journal":{"name":"Addiction and Health","volume":"14 2","pages":"152-163"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b9/f3/ahj-14-152.PMC9743811.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10419585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.22122/AHJ.2022.195484.1212
Seyed Mostafa Mirakbari
COVID-19 infection has become a highly dynamic research field due to the urgent need for a protective approach. The desire for prompt achievements to tackle COVID-19 pandemic has led to the use of controversial drugs, despite safety concerns. Traditional medicinal plants have gained popularity in the last few decades owing to their incomparable chemical diversity and novel mechanisms of action. Currently, both Iranian1 and Chinese2 traditional medicine purport to be effective to control COVID-19; however, none of them recommends the use of opium to mitigate coronavirus spread and mortality. Opium, the latex extracted from the opium poppy (Papaver somniferum), is a complex mixture of chemicals. Its pharmacologically active principles are in its alkaloids. Papaverine, a benzylisoquinoline alkaloid has been shown to have a potent inhibitory effect on the replication of cytomegalovirus, measles, and human immunodeficiency viruses.3 To date, there are some controversies about the impact of opium on COVID-19. Some bogus claims and rumors in social media and the community speculated that opium use may have a protective effect on getting infected with coronavirus.4 Also, some contradictory evidence revealed an opposed association between smoking and COVID-19, delineating the fact that nicotine might possess an immunomodulatory effect to diminish the cytokine storm.5 Thus, there is a newly generated interest in using nicotine as a therapeutic against COVID-19.4,6 On the other hand, lead, an opium adulterant, that enters the blood circulation in both oral and inhaled opium usage 7,8 was found to exaggerate the host response to viruses, resulting in higher mortality rate.9 COVID-19 is rapidly spreading in Afghanistan, the world's largest opium supplier, and Iran’s neighbor, where people are turning to older remedies including opium consumption in the hope of overcoming the pandemic.10 Rumors that the coronavirus has no effect on opioid users have been even extended among educated people. However, these reports did not rely on the available pathogenesis of disease and have severe limitations such as sparse data and lack of evidence-based inference. Inflammation plays a pivotal role in COVID-19 pathogenesis. In fact, opium smokers exhibit mild to moderate inflammation as defined by an increase in acutephase proteins (APPs).11 Also, the plasma levels of IL-6 were higher in opiumaddicted subjects.12 Likewise, the mortality was higher among opium users with COVID-19.4 This is why controlling the inflammatory response may be as important as targeting the virus. In conclusion, as of now, substantial studies contributed to elaborating the notion of the pros and cons of opium's protective properties in the coronavirus pandemic. These pieces of evidence are not conclusive to recommend opium consumption for tackling COVID-19, and the contradictory results do not rule out the available claims of its beneficial effects on the pandemic disease. Thus, the efficacy of opiu
{"title":"Opium consumption and COVID-19: The urgent need for more evidence.","authors":"Seyed Mostafa Mirakbari","doi":"10.22122/AHJ.2022.195484.1212","DOIUrl":"https://doi.org/10.22122/AHJ.2022.195484.1212","url":null,"abstract":"COVID-19 infection has become a highly dynamic research field due to the urgent need for a protective approach. The desire for prompt achievements to tackle COVID-19 pandemic has led to the use of controversial drugs, despite safety concerns. Traditional medicinal plants have gained popularity in the last few decades owing to their incomparable chemical diversity and novel mechanisms of action. Currently, both Iranian1 and Chinese2 traditional medicine purport to be effective to control COVID-19; however, none of them recommends the use of opium to mitigate coronavirus spread and mortality. Opium, the latex extracted from the opium poppy (Papaver somniferum), is a complex mixture of chemicals. Its pharmacologically active principles are in its alkaloids. Papaverine, a benzylisoquinoline alkaloid has been shown to have a potent inhibitory effect on the replication of cytomegalovirus, measles, and human immunodeficiency viruses.3 To date, there are some controversies about the impact of opium on COVID-19. Some bogus claims and rumors in social media and the community speculated that opium use may have a protective effect on getting infected with coronavirus.4 Also, some contradictory evidence revealed an opposed association between smoking and COVID-19, delineating the fact that nicotine might possess an immunomodulatory effect to diminish the cytokine storm.5 Thus, there is a newly generated interest in using nicotine as a therapeutic against COVID-19.4,6 On the other hand, lead, an opium adulterant, that enters the blood circulation in both oral and inhaled opium usage 7,8 was found to exaggerate the host response to viruses, resulting in higher mortality rate.9 COVID-19 is rapidly spreading in Afghanistan, the world's largest opium supplier, and Iran’s neighbor, where people are turning to older remedies including opium consumption in the hope of overcoming the pandemic.10 Rumors that the coronavirus has no effect on opioid users have been even extended among educated people. However, these reports did not rely on the available pathogenesis of disease and have severe limitations such as sparse data and lack of evidence-based inference. Inflammation plays a pivotal role in COVID-19 pathogenesis. In fact, opium smokers exhibit mild to moderate inflammation as defined by an increase in acutephase proteins (APPs).11 Also, the plasma levels of IL-6 were higher in opiumaddicted subjects.12 Likewise, the mortality was higher among opium users with COVID-19.4 This is why controlling the inflammatory response may be as important as targeting the virus. In conclusion, as of now, substantial studies contributed to elaborating the notion of the pros and cons of opium's protective properties in the coronavirus pandemic. These pieces of evidence are not conclusive to recommend opium consumption for tackling COVID-19, and the contradictory results do not rule out the available claims of its beneficial effects on the pandemic disease. Thus, the efficacy of opiu","PeriodicalId":33943,"journal":{"name":"Addiction and Health","volume":"14 2","pages":"164-165"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/04/d8/ahj-14-164.PMC9743810.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10419588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: In the treatment and abstinence of alcoholism, especially in abstinence after treatment, "Craving" has an essential role. Thus, our aim was to examine the effect of cue-exposure therapy on alcohol craving in virtual environment based on the habit loop.
Methods: The present investigation was a case-control experimental study with a pretest-posttest-5 weeks follow-up design. Research population were alcohol-addicted people hospitalized in a psychiatric hospital. We had 62 subjects who had abstained from alcohol consumption. The sampling method was convenience sampling and the sample allocation was randomized and matched. The intervention was VR-CET that was implemented in eight sessions. Penn Alcohol Craving Scale, Alcohol Urge Questionnaire, and Obsessive-Compulsive Drinking Scale were used to collect the data. In order to analyze the data, analysis of covariance (ANCOVA) in SPSS V.23 was performed.
Findings: Our results showed that after implementation of VR-CET program the rate of PACS reduced significantly in posttest stage (p = 0.01) and follow up stage (p= 0.05). Also, the rate of AUQ and OCDS after exposure to VR-CET program declined significantly. The significant level of AUQ and OCDS in posttest and follow up stages were set at p- value < 0.01 and p-value <0.05 respectively.
Conclusion: VR-CET program can reduce alcohol craving by paying attention to various cues and contexts. In fact, it would be more beneficial if the treatment environment resembles a conditioned context and contains as many related cues as possible.
{"title":"Effectiveness of Cue-Exposure Therapy on Alcohol Craving in Virtual Environment: Based on habit loop.","authors":"Alireza Karimpour Vazifehkhorani, Arina Attaran, Azizeh Karimi Saraskandrud, Haniyeh Faghih, Narges Yeganeh","doi":"10.22122/AHJ.2022.196454.1288","DOIUrl":"https://doi.org/10.22122/AHJ.2022.196454.1288","url":null,"abstract":"<p><strong>Background: </strong>In the treatment and abstinence of alcoholism, especially in abstinence after treatment, \"Craving\" has an essential role. Thus, our aim was to examine the effect of cue-exposure therapy on alcohol craving in virtual environment based on the habit loop.</p><p><strong>Methods: </strong>The present investigation was a case-control experimental study with a pretest-posttest-5 weeks follow-up design. Research population were alcohol-addicted people hospitalized in a psychiatric hospital. We had 62 subjects who had abstained from alcohol consumption. The sampling method was convenience sampling and the sample allocation was randomized and matched. The intervention was VR-CET that was implemented in eight sessions. Penn Alcohol Craving Scale, Alcohol Urge Questionnaire, and Obsessive-Compulsive Drinking Scale were used to collect the data. In order to analyze the data, analysis of covariance (ANCOVA) in SPSS V.23 was performed.</p><p><strong>Findings: </strong>Our results showed that after implementation of VR-CET program the rate of PACS reduced significantly in posttest stage (p = 0.01) and follow up stage (p= 0.05). Also, the rate of AUQ and OCDS after exposure to VR-CET program declined significantly. The significant level of AUQ and OCDS in posttest and follow up stages were set at p- value < 0.01 and p-value <0.05 respectively.</p><p><strong>Conclusion: </strong>VR-CET program can reduce alcohol craving by paying attention to various cues and contexts. In fact, it would be more beneficial if the treatment environment resembles a conditioned context and contains as many related cues as possible.</p>","PeriodicalId":33943,"journal":{"name":"Addiction and Health","volume":"14 2","pages":"78-86"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/bc/ahj-14-78.PMC9743816.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10419589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.22122/AHJ.2022.196452.1287
Niall Woodley, Mohd Afiq Mohd Slim, Trung Ton, Jenny Montgomery, Catriona Douglas
Background: The use of opioids is considered a risk factor for laryngeal cancer. A retrospective study was performed to explore the relationship between recreational drug exposure and laryngeal cancer.
Methods: Patients diagnosed between the 1st of January 2013 and the 31st of December 2017 using ICD-10 CD-32 coding were identified from the Head and Neck Multidisciplinary Team database. We divided the study population into two cohorts (RD and non-RD) and compared the demographics, morbidity, and outcomes of these two populations. In addition, we performed case-matched analysis to control for potential confounding factors including gender, alcohol use and cigarette smoking.
Findings: 329 patients in Glasgow, Scotland were included with a mean age of 64.96 ± 10.94 and a follow-up of 24 ± 13.91 months. Of these, 39 reported recreational drug use (RD). RD was associated with younger age (53.0 vs. 66.6, p<0.001) at diagnosis with laryngeal cancer. A greater proportion of tumours occurred in the supraglottic subsite (p=0.041). Furthermore, these patients were more likely to undergo tracheostomy (RR=2.50, 95% CI: 1.41-4.44, p=0.008) and laryngectomy (RR=2.25, 95% CI: 1.57-3.21, p<0.001). Recreational drug users were more likely to require enteral feeding support (RR= 1.44, 95% CI: 1.13-1.84, p=0.02) during oncological treatment. No survival differences were noted at 1, 2, or 3-years (plog-rank=0.83). Case matched analysis correcting for smoking, alcohol and gender confirmed that recreational drug users were younger at diagnosis with a predilection for the supraglottic subsite.
Conclusion: Recreational drug use is associated with an increased burden of disease and morbidity in laryngeal cancer. We suggest that clinicians view recreational drug exposure as a red flag in those with suspected laryngeal cancer regardless of patient age.
背景:阿片类药物的使用被认为是喉癌的危险因素。本研究旨在探讨消遣性药物暴露与喉癌的关系。方法:从头颈部多学科团队数据库中识别2013年1月1日至2017年12月31日使用ICD-10 CD-32编码诊断的患者。我们将研究人群分为两组(RD和非RD),并比较这两组人群的人口统计学、发病率和结局。此外,我们进行了病例匹配分析,以控制潜在的混杂因素,包括性别、饮酒和吸烟。结果:329例患者来自苏格兰格拉斯哥,平均年龄64.96±10.94岁,随访24±13.91个月。其中,39人报告了娱乐性药物使用(RD)。RD与年龄较小相关(53.0 vs 66.6, pplog-rank=0.83)。病例匹配分析校正了吸烟、酒精和性别,证实了娱乐性药物使用者在诊断时更年轻,并倾向于声门上亚位点。结论:消遣性药物使用与喉癌的疾病负担和发病率增加有关。我们建议临床医生将娱乐性药物暴露视为喉癌疑似患者的危险信号,无论患者年龄如何。
{"title":"Does recreational drug use influence survival and morbidity associated with laryngeal cancer.","authors":"Niall Woodley, Mohd Afiq Mohd Slim, Trung Ton, Jenny Montgomery, Catriona Douglas","doi":"10.22122/AHJ.2022.196452.1287","DOIUrl":"https://doi.org/10.22122/AHJ.2022.196452.1287","url":null,"abstract":"<p><strong>Background: </strong>The use of opioids is considered a risk factor for laryngeal cancer. A retrospective study was performed to explore the relationship between recreational drug exposure and laryngeal cancer.</p><p><strong>Methods: </strong>Patients diagnosed between the 1st of January 2013 and the 31st of December 2017 using ICD-10 CD-32 coding were identified from the Head and Neck Multidisciplinary Team database. We divided the study population into two cohorts (RD and non-RD) and compared the demographics, morbidity, and outcomes of these two populations. In addition, we performed case-matched analysis to control for potential confounding factors including gender, alcohol use and cigarette smoking.</p><p><strong>Findings: </strong>329 patients in Glasgow, Scotland were included with a mean age of 64.96 ± 10.94 and a follow-up of 24 ± 13.91 months. Of these, 39 reported recreational drug use (RD). RD was associated with younger age (53.0 vs. 66.6, p<0.001) at diagnosis with laryngeal cancer. A greater proportion of tumours occurred in the supraglottic subsite (p=0.041). Furthermore, these patients were more likely to undergo tracheostomy (RR=2.50, 95% CI: 1.41-4.44, p=0.008) and laryngectomy (RR=2.25, 95% CI: 1.57-3.21, p<0.001). Recreational drug users were more likely to require enteral feeding support (RR= 1.44, 95% CI: 1.13-1.84, p=0.02) during oncological treatment. No survival differences were noted at 1, 2, or 3-years (<sub>plog-rank</sub>=0.83). Case matched analysis correcting for smoking, alcohol and gender confirmed that recreational drug users were younger at diagnosis with a predilection for the supraglottic subsite.</p><p><strong>Conclusion: </strong>Recreational drug use is associated with an increased burden of disease and morbidity in laryngeal cancer. We suggest that clinicians view recreational drug exposure as a red flag in those with suspected laryngeal cancer regardless of patient age.</p>","PeriodicalId":33943,"journal":{"name":"Addiction and Health","volume":"14 2","pages":"115-126"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fa/e7/ahj-14-115.PMC9743818.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10424030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.22122/AHJ.2022.195606.1223
Nasar Ahmad Shayan, Aziz-Ur-Rahman Niazi, Hooman Moheb, Hamid Mohammadi, Khaja Wazir Ahmad Saddiqi, Osman Dag, Hilal Ozcebe
Background: Drug addiction is one of the alarming public health and social problems in Afghanistan and around the world. Addiction denotes the habitual use or the physical or mental dependence on narcotic drugs or psychotropic substances.
Methods: Drug addicts who were admitted to six public addicts' rehabilitation centers in Herat, Afghanistan between March and July 2019 were recruited for this descriptive study. A total of 299 drug addicts were included in this study. A 77-item questionnaire containing three subscales: 39 items for personal information, 32 items for drug use, and 6 items for dependence and treatment subscale were validated and used for data collection. IBM SPSS Statistics for Windows v.22.0 was used for data analyses.
Findings: The median age of the participants was 30 years. Of all participants, 79.1% were male, 56.6% were illiterate, and 1.7% were university graduates. In this study, 44.8% of the participants used heroin, 20.7% used opium and 15.4% used methamphetamine. Almost half of the participants (49.5%) declared that at least one member of their families was a drug user. Of the 299 drug users included in this study, 64.9% stated that at least one person close to them (except family members) used drugs. Over two-thirds of the participants (78.4%) had easy access to drugs, 26.8% had broken laws for money/drugs at least once.
Conclusion: This study revealed that male illiterate teenagers living in low-economic nuclear families were more vulnerable to drug use in Herat, Afghanistan. The most common reasons for drug use were curiosity, peer influence, and seeking pleasure.
背景:吸毒成瘾是阿富汗和世界各地令人震惊的公共卫生和社会问题之一。成瘾是指对麻醉药品或精神药物的习惯性使用或身体上或精神上的依赖。方法:招募2019年3月至7月在阿富汗赫拉特的6个公共成瘾者康复中心接受治疗的吸毒者进行描述性研究。本研究共纳入299名吸毒人员。问卷共77项,包含3个分量表:39项个人信息、32项药物使用、6项依赖和治疗分量表。采用IBM SPSS Statistics for Windows v.22.0进行数据分析。研究结果:参与者的中位年龄为30岁。在所有参与者中,79.1%为男性,56.6%为文盲,1.7%为大学毕业生。在这项研究中,44.8%的参与者使用海洛因,20.7%使用鸦片,15.4%使用甲基苯丙胺。几乎一半(49.5%)的受访者表示家中至少有一名成员吸毒。在本研究纳入的299名吸毒者中,64.9%的人表示至少有一名与其亲近的人(家庭成员除外)吸毒。超过三分之二(78.4%)的受访者很容易获得毒品,26.8%的受访者曾因金钱/毒品而违法至少一次。结论:本研究揭示了生活在阿富汗赫拉特低经济核心家庭的男性文盲青少年更容易吸毒。吸毒最常见的原因是好奇、同伴影响和寻求快乐。
{"title":"Epidemiology of Drug Use in Herat - Afghanistan.","authors":"Nasar Ahmad Shayan, Aziz-Ur-Rahman Niazi, Hooman Moheb, Hamid Mohammadi, Khaja Wazir Ahmad Saddiqi, Osman Dag, Hilal Ozcebe","doi":"10.22122/AHJ.2022.195606.1223","DOIUrl":"https://doi.org/10.22122/AHJ.2022.195606.1223","url":null,"abstract":"<p><strong>Background: </strong>Drug addiction is one of the alarming public health and social problems in Afghanistan and around the world. Addiction denotes the habitual use or the physical or mental dependence on narcotic drugs or psychotropic substances.</p><p><strong>Methods: </strong>Drug addicts who were admitted to six public addicts' rehabilitation centers in Herat, Afghanistan between March and July 2019 were recruited for this descriptive study. A total of 299 drug addicts were included in this study. A 77-item questionnaire containing three subscales: 39 items for personal information, 32 items for drug use, and 6 items for dependence and treatment subscale were validated and used for data collection. IBM SPSS Statistics for Windows v.22.0 was used for data analyses.</p><p><strong>Findings: </strong>The median age of the participants was 30 years. Of all participants, 79.1% were male, 56.6% were illiterate, and 1.7% were university graduates. In this study, 44.8% of the participants used heroin, 20.7% used opium and 15.4% used methamphetamine. Almost half of the participants (49.5%) declared that at least one member of their families was a drug user. Of the 299 drug users included in this study, 64.9% stated that at least one person close to them (except family members) used drugs. Over two-thirds of the participants (78.4%) had easy access to drugs, 26.8% had broken laws for money/drugs at least once.</p><p><strong>Conclusion: </strong>This study revealed that male illiterate teenagers living in low-economic nuclear families were more vulnerable to drug use in Herat, Afghanistan. The most common reasons for drug use were curiosity, peer influence, and seeking pleasure.</p>","PeriodicalId":33943,"journal":{"name":"Addiction and Health","volume":"14 2","pages":"68-77"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/39/ahj-14-68.PMC9743815.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10478928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.22122/AHJ.2022.196722.1179
Raka Jain, Shayani Ghosh, Nizamuddin Saifi
Background: Nonmedical use of prescription drugs for recreational purposes is a major health problem that raises high concerns for public health. Recently, several laboratory studies have reported the misuse of pentazocine, an agonist-antagonist opioid in combination with antihistamines in opioid addicts. Illicit self-administration of prescription drugs has been increasingly reported in India. Urinalysis as an adjunct to self-report plays a key role in providing additional information in the treatment of drug users. This paper aims to discuss a simple, convenient, and rapid capillary column gas-liquid chromatography method for simultaneous detection of pentazocine, pheniramine, and cotinine in urine.
Methods: The sample was extracted with chloroform and isopropanol (3:1,v/v) and evaporated to dryness. After reconstitution with methanol, it was directly subjected to gas chromatography analysis. Method performance was evaluated and validated in terms of sensitivity, precision, the limit of detection (LOD), and the limit of quantification (LOQ).
Findings: The linearity obtained was in the range of 50-1000 ng/ml with a correlation coefficient (r) above 0.999 for each drug. Good LOQ (50ng/ml) was obtained with each drug. Also, the developed method was effective in analyzing samples from patients with suspected abuse of these drugs.
Conclusion: The technique was found to be simple, robust, sensitive, and precise in the simultaneous analysis of drugs (pentazocine, pheniramine, and cotinine). This method was proved to be useful and cost-effective in treating and monitoring patients seeking help for addiction in clinical settings.
{"title":"An efficient method for simultaneous detection of Pheniramine, Pentazocine and cotinine in urine by Gas Chromatography in De-addiction program.","authors":"Raka Jain, Shayani Ghosh, Nizamuddin Saifi","doi":"10.22122/AHJ.2022.196722.1179","DOIUrl":"https://doi.org/10.22122/AHJ.2022.196722.1179","url":null,"abstract":"<p><strong>Background: </strong>Nonmedical use of prescription drugs for recreational purposes is a major health problem that raises high concerns for public health. Recently, several laboratory studies have reported the misuse of pentazocine, an agonist-antagonist opioid in combination with antihistamines in opioid addicts. Illicit self-administration of prescription drugs has been increasingly reported in India. Urinalysis as an adjunct to self-report plays a key role in providing additional information in the treatment of drug users. This paper aims to discuss a simple, convenient, and rapid capillary column gas-liquid chromatography method for simultaneous detection of pentazocine, pheniramine, and cotinine in urine.</p><p><strong>Methods: </strong>The sample was extracted with chloroform and isopropanol (3:1,v/v) and evaporated to dryness. After reconstitution with methanol, it was directly subjected to gas chromatography analysis. Method performance was evaluated and validated in terms of sensitivity, precision, the limit of detection (LOD), and the limit of quantification (LOQ).</p><p><strong>Findings: </strong>The linearity obtained was in the range of 50-1000 ng/ml with a correlation coefficient (r) above 0.999 for each drug. Good LOQ (50ng/ml) was obtained with each drug. Also, the developed method was effective in analyzing samples from patients with suspected abuse of these drugs.</p><p><strong>Conclusion: </strong>The technique was found to be simple, robust, sensitive, and precise in the simultaneous analysis of drugs (pentazocine, pheniramine, and cotinine). This method was proved to be useful and cost-effective in treating and monitoring patients seeking help for addiction in clinical settings.</p>","PeriodicalId":33943,"journal":{"name":"Addiction and Health","volume":"14 2","pages":"96-104"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/10/60/ahj-14-96.PMC9743812.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10419584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.22122/AHJ.2022.196156.1266
Mehran Zarghami, Masoudeh Babakhanian, Abdullah Khavari, Abbas Alipour, Ardeshir Khosravi, Mehdi Saberi
Background: The death registration is conducted by different systems in Iran. The drug-related death registration is exclusively conducted by Ministry of Health and Medical Education (MOHME) and Legal Medicine Organization (LMO). This study investigates the causes of undercounting drug-related deaths (DRDs) in Iran, provides recommendations for addressing this issue, and provides a geographical evaluation of the integrity and quality of drug-related mortality registration (2014-2017).
Methods: This is a mix-method study. In part1, individual targeted interviews were conducted with 12 experts in death registration in MOHME and LMO to collect data on the causes of low registration in Iran and provide recommendations for resolving the issue. Part2 of the study involved an intervention in the form of a memorandum of understanding on reduction of low-registrations. This memorandum was signed to transfer information about the corpses between the MOHME and LMO. First, the number of DRDs (2014- 2017) was examined using capture-recapture method and, then, we calculated and compared the rate of pre-intervention (2014-2016) and post-intervention (2017) under-registration to assess whether this memorandum of understanding had been effective in reduction of under-registrations.
Findings: In part1, according to the participants, the causes of undercounting DRDs in LMO and MOHME were arranged and categorized into 4 categories: weak administration system, physician and personnel training problems, system constraints, and client-related problems. Also, some suggestions were presented to help resolving the problem of undercounting; these suggestions concern the administrative system, technology, and educational domains. In part 2, about half of the provinces in Iran had a positive performance in reducing the undercount.
Conclusion: At the macro level, the memorandum of understanding between the two organizations responsible for registering deaths was effective. However, increasing the quality of data registrations requires monitoring at the micro and organizational levels to lead to a positive performance in reducing death under-registration in all provinces.
{"title":"Drug-related Death low Registration in Iran: A Mixed Method Approach for Causes, Recommendations to Solve This Problem and Geographical Evaluation of an Intervention.","authors":"Mehran Zarghami, Masoudeh Babakhanian, Abdullah Khavari, Abbas Alipour, Ardeshir Khosravi, Mehdi Saberi","doi":"10.22122/AHJ.2022.196156.1266","DOIUrl":"https://doi.org/10.22122/AHJ.2022.196156.1266","url":null,"abstract":"<p><strong>Background: </strong>The death registration is conducted by different systems in Iran. The drug-related death registration is exclusively conducted by Ministry of Health and Medical Education (MOHME) and Legal Medicine Organization (LMO). This study investigates the causes of undercounting drug-related deaths (DRDs) in Iran, provides recommendations for addressing this issue, and provides a geographical evaluation of the integrity and quality of drug-related mortality registration (2014-2017).</p><p><strong>Methods: </strong>This is a mix-method study. In part1, individual targeted interviews were conducted with 12 experts in death registration in MOHME and LMO to collect data on the causes of low registration in Iran and provide recommendations for resolving the issue. Part2 of the study involved an intervention in the form of a memorandum of understanding on reduction of low-registrations. This memorandum was signed to transfer information about the corpses between the MOHME and LMO. First, the number of DRDs (2014- 2017) was examined using capture-recapture method and, then, we calculated and compared the rate of pre-intervention (2014-2016) and post-intervention (2017) under-registration to assess whether this memorandum of understanding had been effective in reduction of under-registrations.</p><p><strong>Findings: </strong>In part1, according to the participants, the causes of undercounting DRDs in LMO and MOHME were arranged and categorized into 4 categories: weak administration system, physician and personnel training problems, system constraints, and client-related problems. Also, some suggestions were presented to help resolving the problem of undercounting; these suggestions concern the administrative system, technology, and educational domains. In part 2, about half of the provinces in Iran had a positive performance in reducing the undercount.</p><p><strong>Conclusion: </strong>At the macro level, the memorandum of understanding between the two organizations responsible for registering deaths was effective. However, increasing the quality of data registrations requires monitoring at the micro and organizational levels to lead to a positive performance in reducing death under-registration in all provinces.</p>","PeriodicalId":33943,"journal":{"name":"Addiction and Health","volume":"14 2","pages":"138-151"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3f/65/ahj-14-138.PMC9743819.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10419587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.22122/AHJ.2022.196722.1314
Apinderjit Kaur, Rakesh Lal, Mahadev Singh Sen, Siddharth Sarkar
Background: Recovery capital helps in the assessment of the personal strengths and challenges that exist in an individual with substance use which may have an impact on recovery process. This study aims at finding out the factors which help such individuals to sustain their recovery and how these factors differ across the two groups of people suffering from Alcohol Dependence Syndrome and Opioid Dependence Syndrome.
Methods: A cross-sectional observational was designed where sociodemographic and clinical variables, the recovery capital ARC (Assessment of Recovery Capital) Scale and Severity of substance use SDS (Severity of Dependence) Scale of patients diagnosed with Alcohol Dependence Syndrome (ADS group) and those with Opioid Dependence Syndrome (ODS group) were assessed among patients not reporting withdrawal symptoms.
Findings: A total of 49 subjects in the ODS group and 30 subjects in the ADS group were enrolled. The majority of the subjects in both groups were married, belonged to urban areas, practiced Hinduism, and were living in nuclear families. There was a significant difference between the educational status (p<0.001), religion practiced (p<0.001), age of onset of dependence (p<0.001), severity of dependence (p=0.11), and duration of abstinence (p<0.001) between the ADS and ODS groups. The mean scores on ARC Scale were 45.9 (S.D. =3.5) in the ODS group and 47.4 (S.D. =4.3) in the ADS group. ADS group had higher scores in Social Support Domain (p=0.034) and Housing and Safety domain (p=0.025). Other domains like global health, citizenship, meaningful activities, risk-taking, coping, and recovery experience did not significantly differ between the groups.
Conclusion: This study aims at comparing the recovery capital of ADS patients with ODS patients. It also suggests that tailored treatment plans for people with ADS and ODS especially in housing and social support and common treatment approach in other domains of recovery will help them sustain the state for a longer term.
{"title":"Comparison of Recovery Capital in Patients with Alcohol and Opioid Dependence - An Exploratory Study.","authors":"Apinderjit Kaur, Rakesh Lal, Mahadev Singh Sen, Siddharth Sarkar","doi":"10.22122/AHJ.2022.196722.1314","DOIUrl":"https://doi.org/10.22122/AHJ.2022.196722.1314","url":null,"abstract":"<p><strong>Background: </strong>Recovery capital helps in the assessment of the personal strengths and challenges that exist in an individual with substance use which may have an impact on recovery process. This study aims at finding out the factors which help such individuals to sustain their recovery and how these factors differ across the two groups of people suffering from Alcohol Dependence Syndrome and Opioid Dependence Syndrome.</p><p><strong>Methods: </strong>A cross-sectional observational was designed where sociodemographic and clinical variables, the recovery capital ARC (Assessment of Recovery Capital) Scale and Severity of substance use SDS (Severity of Dependence) Scale of patients diagnosed with Alcohol Dependence Syndrome (ADS group) and those with Opioid Dependence Syndrome (ODS group) were assessed among patients not reporting withdrawal symptoms.</p><p><strong>Findings: </strong>A total of 49 subjects in the ODS group and 30 subjects in the ADS group were enrolled. The majority of the subjects in both groups were married, belonged to urban areas, practiced Hinduism, and were living in nuclear families. There was a significant difference between the educational status (p<0.001), religion practiced (p<0.001), age of onset of dependence (p<0.001), severity of dependence (p=0.11), and duration of abstinence (p<0.001) between the ADS and ODS groups. The mean scores on ARC Scale were 45.9 (S.D. =3.5) in the ODS group and 47.4 (S.D. =4.3) in the ADS group. ADS group had higher scores in Social Support Domain (p=0.034) and Housing and Safety domain (p=0.025). Other domains like global health, citizenship, meaningful activities, risk-taking, coping, and recovery experience did not significantly differ between the groups.</p><p><strong>Conclusion: </strong>This study aims at comparing the recovery capital of ADS patients with ODS patients. It also suggests that tailored treatment plans for people with ADS and ODS especially in housing and social support and common treatment approach in other domains of recovery will help them sustain the state for a longer term.</p>","PeriodicalId":33943,"journal":{"name":"Addiction and Health","volume":"14 2","pages":"105-114"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/70/37/ahj-14-105.PMC9743817.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10478924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Cigarette smoking is the most important preventable cause of several diseases such as malignancies, pulmonary and cardiovascular diseases. Smoking cessation is now supported by both behavioral counseling and medical pharmacotherapy and is the only effective approach for slowing down an accelerated decline in forced expiratory volume in one second (FEV1). Our study aims to examine changes in forced expiratory volume in one second (FEV1) after smoking cessation for smokers attending our smoking cessation clinic their correlation to smokers' demographic characteristics.
Methods: 114 smokers (48 males and 66 females), with a mean age of 48.36±10.49 years, were enrolled. They were classified in 4 groups, according to their age; <40 years (Group Α), 41-50 years (Group Β), 51-60 years (Group C), >60 years (Group D) and underwent Spirometry on the 1st day of visit, one month (2nd visit) and, 3 months later (3rd visit).
Findings: Statistically significant increase in FEV1 values at the 2nd and 3rd visit compared to the 1st visit was observed in smokers who quit smoking in Group Α, B and C (p<0.05). In addition, a statistically significant decrease in FEV1 values at the 2nd and 3rd visit compared to the 1st visit was noticed in smokers who continued smoking in Group B, C and D (p<0.05).
Conclusion: Smoking cessation achieved through smoking cessation support led to the improvement of FEV1 values within 3 months. The greatest benefit was observed in smokers under the age of 60.
{"title":"Association between smoking cessation and alterations in forced expiratory volume in one second (FEV1). A Follow-Up Study from a Greek Tobacco Cessation Clinic.","authors":"Nikolaos Trakas, Vasiliki Epameinondas Georgakopoulou, Despoina Melemeni, Christos Damaskos, Konstantinos Mantzouranis, Nikolaos Garmpis, Aikaterini Gkoufa, Petros Papalexis, Serafeim Chlapoutakis, Pagona Sklapani, Dimitrios Mermigkis, Agathi Lekkakou, Xanthi Tsiafaki","doi":"10.22122/AHJ.2022.196722.1244","DOIUrl":"https://doi.org/10.22122/AHJ.2022.196722.1244","url":null,"abstract":"<p><strong>Background: </strong>Cigarette smoking is the most important preventable cause of several diseases such as malignancies, pulmonary and cardiovascular diseases. Smoking cessation is now supported by both behavioral counseling and medical pharmacotherapy and is the only effective approach for slowing down an accelerated decline in forced expiratory volume in one second (FEV1). Our study aims to examine changes in forced expiratory volume in one second (FEV1) after smoking cessation for smokers attending our smoking cessation clinic their correlation to smokers' demographic characteristics.</p><p><strong>Methods: </strong>114 smokers (48 males and 66 females), with a mean age of 48.36±10.49 years, were enrolled. They were classified in 4 groups, according to their age; <40 years (Group Α), 41-50 years (Group Β), 51-60 years (Group C), >60 years (Group D) and underwent Spirometry on the 1st day of visit, one month (2nd visit) and, 3 months later (3rd visit).</p><p><strong>Findings: </strong>Statistically significant increase in FEV1 values at the 2<sup>nd</sup> and 3<sup>rd</sup> visit compared to the 1<sup>st</sup> visit was observed in smokers who quit smoking in Group Α, B and C (p<0.05). In addition, a statistically significant decrease in FEV1 values at the 2<sup>nd</sup> and 3<sup>rd</sup> visit compared to the 1<sup>st</sup> visit was noticed in smokers who continued smoking in Group B, C and D (p<0.05).</p><p><strong>Conclusion: </strong>Smoking cessation achieved through smoking cessation support led to the improvement of FEV1 values within 3 months. The greatest benefit was observed in smokers under the age of 60.</p>","PeriodicalId":33943,"journal":{"name":"Addiction and Health","volume":"14 2","pages":"87-95"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/45/6f/ahj-14-87.PMC9743813.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10419586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.22122/AHJ.2022.196559.1295
Ali Saeedi Rashkolia, Alireza Manzari Tavakoli, Zahra Zeinaddiny Meymand, Seyed Mehdi Hosseini Fard
Background: Addiction is a psychiatric disorder with biological, psychological, and social aspects. Literatures indicated that alexithymia, emotional dysregulation, and low psychological capital affect substance abuse. This study investigated the effectiveness of interpersonal psychotherapy on alexithymia, emotional regulation, and psychological capital of male substance abusers.
Methods: This quasi-experimental study was conducted in 2021 in Kerman, Iran using a pretest, post-test design with a control group. A single therapy center was randomly selected via the multi-stage cluster method from several substance abuse treatment centers. 50 people were randomly selected and allocated to experimental and control groups. The research instruments were questionnaires for alexithymia, emotional regulation, and psychological capital. After the pretest phase, the experimental group underwent 12 sessions of interpersonal psychotherapy. In the next step, the post-test was conducted and after 6 weeks the follow-up test was performed on the groups. The control group did not receive the treatment. Finally, the data obtained from 40 participants were analyzed using the MANCOVA test by SPSS25 statistical software.
Findings: Our findings indicated significant MANCOVA results for alexithymia (F=65.14 and P<0.05), emotion regulation (F=44.72 and P<0.05) and psychological capital (F=12.05 and P<0.05) showing a significant difference between the scores of dependent variables in the experimental group and control group.
Conclusion: The results showed that interpersonal psychotherapy improves the state of alexithymia, emotional regulation, and psychological capital in substance abusers. It can also be used as an effective intervention in addiction treatment centers.
{"title":"The Effectiveness of Interpersonal Psychotherapy on Alexithymia, Emotion Regulation, and Psychological Capital of Male Substance Abusers Treated by Addiction Treatment Centers in Kerman.","authors":"Ali Saeedi Rashkolia, Alireza Manzari Tavakoli, Zahra Zeinaddiny Meymand, Seyed Mehdi Hosseini Fard","doi":"10.22122/AHJ.2022.196559.1295","DOIUrl":"https://doi.org/10.22122/AHJ.2022.196559.1295","url":null,"abstract":"<p><strong>Background: </strong>Addiction is a psychiatric disorder with biological, psychological, and social aspects. Literatures indicated that alexithymia, emotional dysregulation, and low psychological capital affect substance abuse. This study investigated the effectiveness of interpersonal psychotherapy on alexithymia, emotional regulation, and psychological capital of male substance abusers.</p><p><strong>Methods: </strong>This quasi-experimental study was conducted in 2021 in Kerman, Iran using a pretest, post-test design with a control group. A single therapy center was randomly selected via the multi-stage cluster method from several substance abuse treatment centers. 50 people were randomly selected and allocated to experimental and control groups. The research instruments were questionnaires for alexithymia, emotional regulation, and psychological capital. After the pretest phase, the experimental group underwent 12 sessions of interpersonal psychotherapy. In the next step, the post-test was conducted and after 6 weeks the follow-up test was performed on the groups. The control group did not receive the treatment. Finally, the data obtained from 40 participants were analyzed using the MANCOVA test by SPSS25 statistical software.</p><p><strong>Findings: </strong>Our findings indicated significant MANCOVA results for alexithymia (F=65.14 and P<0.05), emotion regulation (F=44.72 and P<0.05) and psychological capital (F=12.05 and P<0.05) showing a significant difference between the scores of dependent variables in the experimental group and control group.</p><p><strong>Conclusion: </strong>The results showed that interpersonal psychotherapy improves the state of alexithymia, emotional regulation, and psychological capital in substance abusers. It can also be used as an effective intervention in addiction treatment centers.</p>","PeriodicalId":33943,"journal":{"name":"Addiction and Health","volume":"14 2","pages":"127-137"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/89/4f/ahj-14-127.PMC9743814.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10478929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}